Managing immune dysregulation resulting from immune checkpoint inhibitors: impact of the ASCO guidelines and key take-homes for immunologists. (4th March 2019)

Record Type:: Journal Article
Title:: Managing immune dysregulation resulting from immune checkpoint inhibitors: impact of the ASCO guidelines and key take-homes for immunologists. (4th March 2019)
Main Title:: Managing immune dysregulation resulting from immune checkpoint inhibitors: impact of the ASCO guidelines and key take-homes for immunologists
Authors:: Kim, Sang T.
Suarez-Almazor, Maria E.
Abstract:
Is Part Of:: Expert review of clinical immunology. Volume 15:Number 3(2019)
Journal:: Expert review of clinical immunology
Issue:: Volume 15:Number 3(2019)
Issue Display:: Volume 15, Issue 3 (2019)
Year:: 2019
Volume:: 15
Issue:: 3
Issue Sort Value:: 2019-0015-0003-0000
Page Start:: 211
Page End:: 213
Publication Date:: 2019-03-04
Subjects:: Cancer immunotherapy -- immune checkpoint inhibitors -- immune-related adverse events -- clinical practice guidelines -- toxicity
Clinical immunology -- Periodicals
616.079
Journal URLs:: http://www.tandfonline.com/toc/ierm20/current ↗
http://www.future-drugs.com/loi/eci ↗
http://informahealthcare.com ↗
DOI:: 10.1080/1744666X.2019.1559731 ↗
Languages:: English
ISSNs:: 1744-666X
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3842.002985
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store
Ingest File:: 9527.xml